期刊文献+

MMP-2、MMP-9、TIMP-1和TIMP-2在乳腺癌中的表达及临床意义 被引量:15

Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in breast carcinomas and their clinical significance
下载PDF
导出
摘要 目的 研究MMP 2、MMP 9、TIMP 1和TIMP 2在乳腺癌中的表达及与临床病理特征的关系。方法 免疫组化SP法检测 66例原发性乳腺癌、1 3例乳腺纤维腺瘤和 1 5例乳腺纤维腺病中的蛋白表达。结果 ①乳腺癌中MMP 2、MMP 9的阳性表达显著高于乳腺纤维腺瘤和纤维腺病 (P <0 0 5) ;②MMP 9的阳性表达与乳腺癌肿瘤大小、临床分期呈正相关 (P <0 0 5) ,伴腋窝淋巴结转移的乳腺癌中MMP 9、MMP 2呈高表达 ,但TIMP 1显著低表达 ;乳腺癌中MMP 9与TIMP 1的表达呈负相关 (P <0 0 5) ;③MMP 2、MMP 9表达的乳腺癌患者预后差。结论 乳腺癌中MMP 2、MMP 9表达显著高于乳腺良性病变 ; Objective To study the expression and prognosti c significance of matrix metalloproteinase 2 protein (MMP-2), matrix metalloprot einase 9 protein (MMP-9), tissue inhibitor of matrix metalloproteinase 1 prot ein (TIMP-1) and tissue inhibitor of matrix metalloproteinase 2 protein (TIMP -2) in the breast carcinomas and benign breast diseases Methods Total 66 cases of breast cancers with follow-up, 13 breast fibroadenoma a nd 15 breast fibroadenomatosis were investigated by immunohistochemical staining with anti MMP-2, MMP-9, anti TIMP-1 and TIMP-2 monoclonal antibodies Results The expr ession of MMP-2 and MMP-9 was significantly higher in the breast cancers than those of breast fibroadenoma and fibroadenomatosis (P<0 05) There was a positive association between the expression of MMP-9 and size of the breast can cer, short survival time and TNM classification respectively (P<0 05). Ove rexpression of MMP-2 and MMP-9 in the breast cancers with axillary lymph node involvement was significantly higher than that without node metastases (P<0 05), but overexpression of TIMP-1 was reverse (P<0 05) Negative corre lation between expression of TIMP-1 and that of MMP-9 in breast cancer was obs erved (P<0 05). In both life tables and monovariate Kaplan-Meir plot anal ysis, expression of MMP-2 and MMP-9 proteins was correlated with unfavorable p rognosis Conclusions High activities of MMP-2 and MMP-9 en hances the tumor growth and the capacity to invade locally and metastasize Fur thermore, MMP-2 and MMP-9 proteins associate strongly with a shorted survival, and act as prognostic markers for patients with breast cancer after operation
出处 《诊断病理学杂志》 CSCD 2003年第2期99-101,T030,共4页 Chinese Journal of Diagnostic Pathology
关键词 MMP-2 MMP-9 TIMP-1 TIMP-2 乳腺癌 表达 临床意义 Breast Cancer Matrix metalloproteinases Tissue inhibitors of matrix metalloproteinases Prognosis
  • 相关文献

参考文献7

  • 1李莉,张声,林华,林建银.基质金属蛋白酶和组织金属蛋白酶抑制剂表达失衡与胃癌浸润转移的关系[J].癌症,2002,21(3):305-310. 被引量:57
  • 2王岩,刘晓霞,侯正文,柳春晖,马秀萍,陈丽萍,贾支红,方虹.基质金属蛋白酶及其抑制剂在乳腺癌转移、浸润中的作用[J].临床与实验病理学杂志,2002,18(3):273-275. 被引量:12
  • 3Nawrocki B, Polette M, Marchand Vet al . Exppression of matrix metallo-proteinase and their inhibitor in human bronchopnlmonary carcinomas:quantificative and morphdogital analyses, Int J Cancer, 1997,72: 556.
  • 4Heppner KJ, Matrisian LM, Jonsen RA et al .Expression of most matrix metalloproteinase family members in breast cancer represonts a tumor induced host response.Am J Pathol, 1996,149:273.
  • 5Yoshikawa T,Saitoh M,Tsuburaya A et al .Tissue inhibitor of matrix metalloprotease-1 in the plasma of patients with gastric carcinoma:a possible marker for serosal invasion and metastasis. Cancer, 1999,86:1929.
  • 6Luparello C, Avanzato G, Carella C et al .Tissue inhibitor of metalloprotease(TIMP-1 ) and proliferative behaviour of clonal breast cancer cells. Breast Cancer Res Treat, 1999,54:235.
  • 7Talvensaari MA, Paakko P, Hoyhtya M et al .Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma.Cancer, 1998,83 : 1153.

二级参考文献14

  • 1Chesler L, Golde DW, Bersch N, et al. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1 [J]. Blood, 1995, 86: 4506-4515.
  • 2Aznavoorian S, Murphy AN, Stetler Stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis [J]. Cancer, 1993, 71:1368-1383.
  • 3Ramos DeSimone N, Hahn Dantona E, Sipley J, et al. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion [J]. J Biol Chem, 1999, 274(19):13066-13076.
  • 4Goldverg GJ, Strongin A, Collier IE, et al. Interaction of 92 kDa type Ⅳ collagenase with tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase and activation of proenzyme with stromelysin [J]. J Biol Chem, 1992, 267:4583-4591.
  • 5Watanabe M, Takahashi Y, Ohta T, et al. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice [J]. Cancer 1996, 77:1676-1680.
  • 6Murray GI, Duncan ME, Arbuckle E, et al. Matrix metalloproteinases and their inhibitors in gastric cancer [J]. Gut, 1998, 43: 791-797
  • 7Davies B, Miles DW, Happerefield IC, et al. Activity of type Ⅳ collagenases in benign and malignant breast disease [J]. Br J Cancer, 1993, 67:1126-1131.
  • 8Torii A, Kodera Y, Uesaka K, et al. Plasma concentration of matrix metalloproteinase 9 in gastric cancer [J]. Br J Surg, 1997, 84: 133-136.
  • 9Sier CF, Kubben FJ, Ganesh S, et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma [J]. Br J Cancer, 1996, 74: 413-417.
  • 10Mimori K, Mori M, Shiraishi T, et al. Clinical signification of tissue inhibitor of metalloproteinase expression in gastric carcinoma [J]. Br J Cancer, 1997, 76: 531-536.

共引文献64

同被引文献114

引证文献15

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部